Pacific Industries Rights Issue 2023 vs Shukra Pharmaceuticals Rights Issue 2023

Comparision between Pacific Industries Rights Issue 2023 and Shukra Pharmaceuticals Rights Issue 2023.

Rights Issue details

Find important information like Listing Exchange, Terms of payment and Entitlement Ratio for Pacific Industries Rights Issue 2023 and Shukra Pharmaceuticals Rights Issue 2023. Pacific Industries Rights Issue 2023 is listed on BSE while Shukra Pharmaceuticals Rights Issue 2023 is listed on BSE.

	Pacific Industries Limited	Shukra Pharmaceuticals Limited
Logo
Listing At	BSE	BSE
Terms of Payment	The full amount is payable on application.	Rs. 5 per Rights Equity Share to be paid on Application and balance to be paid in three calls as determined.
Entitlement	1 Rights Equity Share for every 1 fully paid-up Equity Share	6 Equity Shares for every 1 Fully Paid Equity Share held
Application Form	Application Form	Application Form
Letter of Offer	Letter of Offer	Letter of Offer
Registrar	Link Intime India Private Ltd	Purva Sharegistry India Pvt Ltd
Lead Managers	Srujan Alpha Capital Advisors Llp

Rights Issue Size and Price

The issue size of Pacific Industries Rights Issue 2023 rights issue is ₹47.90 Crores, whereas Shukra Pharmaceuticals Rights Issue 2023 rights issue size is ₹18.79 Crores.

	Pacific Industries Limited	Shukra Pharmaceuticals Limited
Issue Size	34,46,325 shares	93,94,050 shares
Issue Size (Amount)	₹47.90 Crores	₹18.79 Crores
Issue Price	₹139 per share	₹20 per share
Face Value	₹10 per share	₹10 per share

Rights Issue Timetable

Find all the important dates related to the rights issue. The record date of Pacific Industries Rights Issue 2023 is Jan 11, 2023 while record date of Shukra Pharmaceuticals Rights Issue 2023 is Feb 02, 2023.

	Pacific Industries Limited	Shukra Pharmaceuticals Limited
Record Date	Jan 11, 2023	Feb 02, 2023
Credit of Rights Entitlements	Jan 13, 2023	Feb 13, 2023
Bid/Offer Opens On	Jan 19, 2023	Feb 15, 2023
Renunciation of Rights Entitlements	Jan 30, 2023	Feb 23, 2023
Bid/Offer Closes On	Feb 02, 2023	Feb 28, 2023
Deemed Date of Allotment	Feb 10, 2023	Mar 08, 2023
Credit Date	Feb 13, 2023	Mar 14, 2023
Listing Date	Feb 15, 2023	Mar 15, 2023

Financials details

Comparison of Pacific Industries Rights Issue 2023 and Shukra Pharmaceuticals Rights Issue 2023 financial data, including total revenue, PAT, and net worth. The table below also includes a list of all relevant documents like the Application Form and Letter of Offer. Related Parties like Lead Manager and Registrar are also mentioned in this section.

Pacific Industries Limited

Shukra Pharmaceuticals Limited

Financial

Pacific Industries Limited Financial Information (Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax
31-Mar-21	475.18	185.86	10.41
31-Mar-22	510.58	293.42	15.92
Amount in ₹ Crore

Shukra Pharmaceuticals Limited Financial Information (Consolidated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth
31-Mar-21	35.61	11.55	0.19	15.60
31-Mar-22	35.11	20.57	0.75	16.35
Amount in ₹ Crore

Compare with others

Pacific Industries Limited	Shukra Pharmaceuticals Limited
Markolines Pavement Technologies Rights Issue 2023	Bright Solar Rights Issue 2023
Hazoor Multi Projects Rights Issue 2023	Parvati Sweetners and Power Rights Issue 2023
Shukra Pharmaceuticals Rights Issue 2023	Shree Ganesh Remedies Rights Issue 2023
Vaxfab Enterprises Rights Issue 2023	Markolines Pavement Technologies Rights Issue 2023
Aarti Surfactants Rights Issue 2023	Hazoor Multi Projects Rights Issue 2023
Jet Freight Logistics Rights Issue 2023	Vaxfab Enterprises Rights Issue 2023
Family Care Hospitals Rights Issue 2022	Aarti Surfactants Rights Issue 2023
AKG EXIM Rights Issue 2022	Pacific Industries Rights Issue 2023
Indowind Energy Rights Issue 2022	Jet Freight Logistics Rights Issue 2023
Visagar Financial Services Rights Issue 2022	Family Care Hospitals Rights Issue 2022

Comments

Add a public comment...